Nonseminomatous germ cell tumors: Assessing the need for postchemotherapy contralateral pulmonary resection in patients with ipsilateral complete necrosis

被引:40
作者
Besse, Benjamin
Grunenwald, Dominique [5 ]
Flechon, Aude [7 ]
Caty, Armelle [6 ]
Chevreau, Christine [4 ]
Culine, Stephane [3 ]
Theodore, Christine [2 ]
Fizazi, Karim [1 ]
机构
[1] Inst Gustave Roussy, Dept Med, Genito Urinary Grp, F-94805 Villejuif, France
[2] Hop Foch, Suresnes, France
[3] Ctr Val Aurelle Paul Lamarque, Montpellier, France
[4] Inst Claudius Regaud, Toulouse, France
[5] Hop Tenon, F-75970 Paris, France
[6] Ctr Oscar Lambret, F-59020 Lille, France
[7] Ctr Leon Berard, F-69373 Lyon, France
关键词
RETROPERITONEAL MASS HISTOLOGY; POSITRON-EMISSION-TOMOGRAPHY; LYMPH-NODE DISSECTION; TESTICULAR CANCER; RESIDUAL MASSES; CHEMOTHERAPY; SURGERY; PREDICTION; EXPERIENCE; PROGNOSIS;
D O I
10.1016/j.jtcvs.2008.09.032
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Our objective was to explore the pathologic components of residual masses after primary chemotherapy in patients with metastatic nonseminomatous germ cell tumors. Methods: A multicenter retrospective study was conducted of 71 patients with thoracic residual masses (39 patients had bilateral lung metastasis) after first-line cisplatin-based chemotherapy for disseminated nonseminomatous germ cell tumors. Among the 71 patients, 52 also had a retroperitoneal lymph node dissection. Results: Pathologic findings in postchemotherapy residual masses included complete necrosis, teratoma, and viable cancer in 31%, 55%, and 14% of patients, respectively. Discordant pathologic findings were evidenced between retroperitoneal lymph node and thoracic (lung or mediastinal lymph nodes) residual masses in 27% of patients. When a bilateral pulmonary resection was performed, only 2 (5%) of 39 patients had discordant histologic findings between the two lungs. Among patients who had necrosis only in residual masses from their first lung (n = 20), 19 (95%) also had necrosis only in contralateral lesions. A single patient had necrosis only in the first lung and some teratoma in the contralateral lung. Conclusions: This report shows a high rate (95%) of pathologic concordance between the two lungs. Avoiding contralateral lung surgery could therefore be considered when complete necrosis is found in the first lung after induction chemotherapy for nonseminomatous germ cell tumor.
引用
收藏
页码:448 / 452
页数:5
相关论文
共 25 条
[1]   Dermatologic side effects associated with the epidermal growth factor receptor inhibitors [J].
Agero, Anna Liza C. ;
Dusza, Stephen W. ;
Benvenuto-Andrade, Cristiane ;
Busam, Klaus J. ;
Myskowski, Patricia ;
Halpern, Allan C. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 55 (04) :657-670
[2]   The growing teratoma syndrome:: results of therapy and long-term follow-up of 33 patients [J].
André, F ;
Fizazi, K ;
Culine, S ;
Droz, JP ;
Taupin, P ;
Lhommé, C ;
Terrier-Lacombe, MJ ;
Théodore, C .
EUROPEAN JOURNAL OF CANCER, 2000, 36 (11) :1389-1394
[3]   Testicular germ-cell cancer [J].
Bosl, GJ ;
Motzer, RJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (04) :242-253
[4]   Assessing prognosis and optimizing treatment in patients with postchemotherapy viable nonseminomatous germ-cell tumors (NSGCT): results of the sCR2 international study [J].
Fizazi, K. ;
Oldenburg, J. ;
Dunant, A. ;
Chen, I. ;
Salvioni, R. ;
Hartmann, J. T. ;
De Santis, M. ;
Daugaard, G. ;
Flechon, A. ;
de Giorgi, U. ;
Tjulandin, S. ;
Schmoll, H. J. ;
Bouzy, J. ;
Fossa, S. D. ;
Fromont, G. .
ANNALS OF ONCOLOGY, 2008, 19 (02) :259-264
[5]   Early predicted time to normalization of tumor markers predicts outcome in poor-prognosis nonseminomatous germ cell tumors [J].
Fizazi, K ;
Culine, S ;
Kramar, A ;
Amato, RJ ;
Bouzy, J ;
Chen, I ;
Droz, JP ;
Logothetis, CJ .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (19) :3868-3876
[6]   Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors:: Prognostic factors and role of postsurgery chemotherapy-results from an international study group [J].
Fizazi, K ;
Tjulandin, S ;
Salvioni, R ;
Germà-Lluch, JR ;
Bouzy, J ;
Ragan, D ;
Bokemeyer, C ;
Gerl, A ;
Fléchon, A ;
de Bono, JS ;
Stenning, S ;
Horwich, A ;
Pont, J ;
Albers, P ;
De Giorgi, U ;
Bower, M ;
Bulanov, A ;
Pizzocaro, G ;
Aparicio, J ;
Nichols, CR ;
Théodore, C ;
Hartmann, JT ;
Schmoll, HJ ;
Kaye, SB ;
Culine, S ;
Droz, JP ;
Mahé, C .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (10) :2647-2657
[7]   HISTOLOGY OF TUMOR RESIDUALS FOLLOWING CHEMOTHERAPY IN PATIENTS WITH ADVANCED NONSEMINOMATOUS TESTICULAR CANCER [J].
FOSSA, SD ;
AASS, N ;
OUS, S ;
HOIE, J ;
STENWIG, AE ;
LIEN, HH ;
PAUS, E ;
KAALHUS, O .
JOURNAL OF UROLOGY, 1989, 142 (05) :1239-1242
[8]   Clinical pattern and therapeutic results achieved in 1490 patients with germ-cell tumours of the testis:: the experience of the Spanish Germ-Cell Cancer Group (GG) [J].
Germà-Lluch, JR ;
del Muro, XG ;
Maroto, P ;
Paz-Ares, L ;
Arranz, JA ;
Gumà, J ;
Alba, E ;
Sastre, J ;
Aparicio, J ;
Fernández, A ;
Barnadas, A ;
Terrassa, J ;
Sáenz, A ;
Almenar, D ;
López-Brea, M ;
Climent, MA ;
Sánchez, MA ;
de la Vega, RL ;
Berenguer, G ;
Pérez, C .
EUROPEAN UROLOGY, 2002, 42 (06) :553-562
[9]   Comparison of histological results from the resection of residual masses at different sites after chemotherapy for metastatic non-seminomatous germ cell tumours [J].
Hartmann, JT ;
Candelaria, M ;
Kuczyk, MA ;
Schmoll, HJ ;
Bokemeyer, C .
EUROPEAN JOURNAL OF CANCER, 1997, 33 (06) :843-847
[10]   Mediastinal metastases from testicular nonseminomatous germ cell tumors: Patterns of dissemination and predictors of long-term survival with surgery [J].
Kesler, KA ;
Brooks, JA ;
Rieger, KM ;
Fineberg, NS ;
Einhorn, LH ;
Brown, JW .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2003, 125 (04) :913-923